GGrantIndex
← Leaderboards

David S. Rickman

Weill Medical Coll Of Cornell Univ

Google Scholar ↗PubMed ↗ORCID ↗
$6,692,454
Attributed
$9,067,473
Total exposure
6
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.3M · FY2010–25
$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$9,067,473 · 6

By mechanism

R01$6,908,116 · 4
P50$1,759,435 · 1
R21$399,922 · 1

Top collaborators

Most similar at Weill Medical Coll Of Cornell Univ

Same institution · by research overlap

Others in their field

Top investigators on “Insight”

Research focus

InsightMolecularResistanceMalignant Neoplasm Of ProstateTumorIn VitroAndrogensMultidisciplinaryMediatingPatient SelectionGene ExpressionPersonalized Cancer CareAndrogen ReceptorIn VivoBaseNeoplastic CellCell SurvivalCastration Resistant Prostate CancerCancer PatientCastrationPhenotypeEpigenomicsOrganoidsReceptor Signaling

Grant awards (21)

The role of early oncogenic drivers in maintaining lineage fidelity in prostate cancer$683,979
R01 · FY2025 · CA
"DNMT and TET1 reprogramming as a targetable mechanism of resistance in advanced prostate cancer"$645,518
R01 · FY2025 · CA · contact PI
"DNMT and TET1 reprogramming as a targetable mechanism of resistance in advanced prostate cancer"$613,243
R01 · FY2024 · CA · contact PI
"DNMT and TET1 reprogramming as a targetable mechanism of resistance in advanced prostate cancer"$662,893
R01 · FY2023 · CA · contact PI
Defining Molecular Determinants of Lineage Plasticity as a Mechanism of Treatment Resistance in Prostate Cancer$419,529
R01 · FY2023 · CA · contact PI
Defining Molecular Determinants of Lineage Plasticity as a Mechanism of Treatment Resistance in Prostate Cancer$419,529
R01 · FY2022 · CA · contact PI
Defining Molecular Determinants of Lineage Plasticity as a Mechanism of Treatment Resistance in Prostate Cancer$428,090
R01 · FY2021 · CA · contact PI
Project 2: Targeting N-Myc and EZH2-driven Castrate Resistant Prostate Cancer$343,882
P50 · FY2021 · CA · contact PI
Defining Molecular Determinants of Lineage Plasticity as a Mechanism of Treatment Resistance in Prostate Cancer$428,090
R01 · FY2020 · CA · contact PI
Project 2: Targeting N-Myc and EZH2-driven Castrate Resistant Prostate Cancer$351,277
P50 · FY2020 · CA · contact PI
Defining Molecular Determinants of Lineage Plasticity as a Mechanism of Treatment Resistance in Prostate Cancer$462,840
R01 · FY2019 · CA · contact PI
Project 2: Targeting N-Myc and EZH2-driven Castrate Resistant Prostate Cancer$343,882
P50 · FY2019 · CA · contact PI
Mechanistic Insights Underlying ERG-induced Taxane Resistance in Castration-Resis$428,881
R01 · FY2018 · CA · contact PI
Project 2: Targeting N-Myc and EZH2-driven Castrate Resistant Prostate Cancer$369,766
P50 · FY2018 · CA · contact PI
Mechanistic Insights Underlying ERG-induced Taxane Resistance in Castration-Resis$428,881
R01 · FY2017 · CA · contact PI
Project 2: Targeting N-Myc and EZH2-driven Castrate Resistant Prostate Cancer$350,628
P50 · FY2017 · CA · contact PI
Mechanistic Insights Underlying ERG-induced Taxane Resistance in Castration-Resis$428,881
R01 · FY2016 · CA · contact PI
Mechanistic Insights Underlying ERG-induced Taxane Resistance in Castration-Resis$428,881
R01 · FY2015 · CA · contact PI
Mechanistic Insights Underlying ERG-induced Taxane Resistance in Castration-Resis$428,881
R01 · FY2014 · CA · contact PI
Understanding the biology of taxane response in the context of ETS rearranged pro$142,619
R21 · FY2011 · CA · contact PI
Understanding the biology of taxane response in the context of ETS rearranged pro$257,303
R21 · FY2010 · CA · contact PI